CLINICAL_TRIALS ClinicalTrials.gov record update

An Open Label, Randomized Comparison of Femara® 2.5mg Once Daily With or Without Weekly Herceptin® Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00171847
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:00.079251+00:00
Published At: 2010-03-31T00:00:00+00:00
Record Updated At: 2010-03-31
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-03-31"
protocolSection.identificationModule.nctId: "NCT00171847"
protocolSection.identificationModule.officialTitle: "An Open Label, Randomized Comparison of Femara\u00ae 2.5mg Once Daily With or Without Weekly Herceptin\u00ae Until Disease Progression as First-line Treatment in Postmenopausal Women With Advanced Breast Cancer."
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.